These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23565456)

  • 41. Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with Type 2 Diabetes.
    Saif-Ali R; Kamaruddin NA; Al-Habori M; Al-Dubai SA; Ngah WZW
    Diabetol Metab Syndr; 2020; 12():67. PubMed ID: 32774471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report.
    Lim SC; Tai ES; Tan BY; Chew SK; Tan CE
    Diabetes Care; 2000 Mar; 23(3):278-82. PubMed ID: 10868851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Insulin secretion and insulin sensitivity in 1193 inpatients with essential hypertension].
    Tang XF; Li H; Wang JG; Chu SL; Guo JZ; Zhu DL
    Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):735-9. PubMed ID: 15631823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic syndrome does not increase the risk of conversion of impaired glucose tolerance to diabetes in Asian Indians--Result of Indian diabetes prevention programme.
    Ramachandran A; Snehalatha C; Satyavani K; Sivasankari S; Vijay V
    Diabetes Res Clin Pract; 2007 May; 76(2):215-8. PubMed ID: 16982107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study.
    Li Y; Feng D; Esangbedo IC; Zhao Y; Han L; Zhu Y; Fu J; Li G; Wang D; Wang Y; Li M; Gao S; Willi SM
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China).
    Wang F; Ye P; Hu D; Min Y; Zhao S; Wang Y; Mu Y; Yan X; Li Z; Wei Y; Li J;
    Atherosclerosis; 2014 Nov; 237(1):99-105. PubMed ID: 25238215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance.
    Meshkani R; Taghikhani M; Larijani B; Khatami S; Khoshbin E; Adeli K
    Clin Chim Acta; 2006 Sep; 371(1-2):169-75. PubMed ID: 16714005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
    Özalp Kızılay D; Şen S; Ersoy B
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spectrum of lipid and lipoprotein indices in human subjects with insulin resistance syndrome.
    Khan SH; Khan FA; Ijaz A; Sattar A; Dilawar M; Hashim R
    J Ayub Med Coll Abbottabad; 2008; 20(3):17-22. PubMed ID: 19610507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased Metabolic Disorders and Impaired Insulin Secretory Function in the First-Degree Relatives of Type 2 Diabetic Patients with Normal Glucose Tolerance.
    Deng L; Liu S; Gong Y; Tian H; Liu Y; Song J; Ran X; Yu H; Zhang X; Long Y; Ren Y
    Metab Syndr Relat Disord; 2016 Nov; 14(9):431-436. PubMed ID: 27689409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease.
    Sesti G; Hribal ML; Fiorentino TV; Sciacqua A; Perticone F
    BMJ Open Diabetes Res Care; 2014; 2(1):e000016. PubMed ID: 25452862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Examining dyslipidaemia, metabolic syndrome and liver enzyme levels in patients with prediabetes and type 2 diabetes in population from Hoveyzeh cohort study: A case-control study in Iran.
    Dinarvand N; Cheraghian B; Rahimi Z; Salehipour Bavarsad S; Bavarsad A; Mohammadtaghvaei N
    Endocrinol Diabetes Metab; 2023 Mar; 6(2):e401. PubMed ID: 36597273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance.
    Zhang F; Tang X; Cao H; Lü Q; Li N; Liu Y; Zhang X; Zhang Y; Cao M; Wan J; An Z; Tong N
    Int J Med Sci; 2012; 9(7):574-81. PubMed ID: 22991496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.
    Ferjan S; Janez A; Jensterle M
    Endocr Pract; 2018 Jan; 24(1):69-77. PubMed ID: 29144805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.